HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 169 filers reported holding HAEMONETICS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,358,000 | -18.8% | 59,700 | -16.6% | 0.05% | -17.5% |
| Q1 2017 | $2,905,000 | +0.9% | 71,600 | 0.0% | 0.06% | -1.7% |
| Q4 2016 | $2,878,000 | +3.7% | 71,600 | -6.5% | 0.06% | -6.5% |
| Q3 2016 | $2,774,000 | +24.9% | 76,600 | 0.0% | 0.06% | +24.0% |
| Q2 2016 | $2,221,000 | +0.6% | 76,600 | +21.4% | 0.05% | +8.7% |
| Q1 2016 | $2,207,000 | +8.5% | 63,100 | 0.0% | 0.05% | +24.3% |
| Q4 2015 | $2,034,000 | +11.0% | 63,100 | +11.3% | 0.04% | +19.4% |
| Q3 2015 | $1,833,000 | +11.1% | 56,700 | +42.1% | 0.03% | +34.8% |
| Q2 2015 | $1,650,000 | -7.9% | 39,900 | 0.0% | 0.02% | -4.2% |
| Q1 2015 | $1,792,000 | -21.1% | 39,900 | -34.3% | 0.02% | -20.0% |
| Q4 2014 | $2,271,000 | +7.1% | 60,700 | 0.0% | 0.03% | +7.1% |
| Q3 2014 | $2,120,000 | – | 60,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |